Cerepak Brad M (Insider) reported special transactions (Non-P/S).
Cerepak Brad M (Insider) reported special transactions (Non-P/S).
Kueppers Eric (Insider) reported special transactions (Non-P/S).
Kueppers Eric (Insider) reported special transactions (Non-P/S).
Ostermann Douglas R (Chief Financial Officer) reported special transactions (Non-P/S).
Ostermann Douglas R (Chief Financial Officer) reported special transactions (Non-P/S).
Vinci Sharon (Chief People Officer) reported special transactions (Non-P/S).
Vinci Sharon (Chief People Officer) reported special transactions (Non-P/S).
Acosta Janis N (CLO and Secretary) reported special transactions (Non-P/S).
Acosta Janis N (CLO and Secretary) reported special transactions (Non-P/S).
Tamez Armando (Insider) reported special transactions (Non-P/S).
Tamez Armando (Insider) reported special transactions (Non-P/S).
Alving Amy E (Insider) reported special transactions (Non-P/S).
Alving Amy E (Insider) reported special transactions (Non-P/S).
CLARK KEVIN P (Insider) reported special transactions (Non-P/S).
CLARK KEVIN P (Insider) reported special transactions (Non-P/S).
MEISTER PAUL M (Insider) reported special transactions (Non-P/S).
MEISTER PAUL M (Insider) reported special transactions (Non-P/S).
CELIAN JASON (Chief Accounting Officer) reported special transactions (Non-P/S).
CELIAN JASON (Chief Accounting Officer) reported special transactions (Non-P/S).
Liotine Joseph T. (CEO and Director) reported special transactions (Non-P/S).
Liotine Joseph T. (CEO and Director) reported special transactions (Non-P/S).
WINTON GROUP Ltd bought a new position in Versigent (NYSE:VGNT – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 199,883 shares of the company’s stock, valued…
WINTON GROUP Ltd bought a new position in Versigent (NYSE:VGNT – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 199,883 shares of the company’s stock, valued…
Several analysts have recently updated their ratings and price targets for Versigent (NYSE: VGNT): 8/13/2026 – Versigent had its price target raised by Argus from $50.00 to $54.00. They now have a “buy” rating on the stock. 8/10/2026…
Several analysts have recently updated their ratings and price targets for Versigent (NYSE: VGNT): 8/13/2026 – Versigent had its price target raised by Argus from $50.00 to $54.00. They now have a “buy” rating on the stock. 8/10/2026…
https://fundspec.ai
Build custom AI trading models for VGNT with the FundSpec App!
https://fundspec.ai
Build custom AI trading models for VGNT with the FundSpec App!
https://www.stocktitan.net/news/VGNT/versigent-reports-second-quarter-2026-3xhqvry5q17c.html
https://www.stocktitan.net/news/VGNT/versigent-reports-second-quarter-2026-3xhqvry5q17c.html
https://www.stocktitan.net/news/VGNT/versigent-announces-second-quarter-2026-earnings-xg1cp2k2ff4b.html
https://www.stocktitan.net/news/VGNT/versigent-announces-second-quarter-2026-earnings-xg1cp2k2ff4b.html